Skip to main content

Bioinformatics Startup X-Mine Licenses Software to BioCardia

NEW YORK, Nov. 13 – Bioinformatics startup X-Mine said it has licensed its data-mining platform to BioCardia,  a developer of technologies and products designed to improve cardiac care

Under the terms of the deal, BioCardia, of South San Francisco, Calif., will also have early access to X-Mine’s future molecular pattern recognition and computational tools. 

“BioCardia is excited about this agreement with X-Mine, because we believe that X-Mine has a world class team of experts and a state of the art platform which can provide us with a substantial competitive advantage,” BioCardia CEO Peter Altman, said in a statement released Monday. 

X-Mine of Brisbane, Calif., markets X-Miner, a molecular pattern recognition software tool that provides users with insight into gene expression and proteomic data.

Financial terms of the deal were not disclosed.


The Scan

UK Funds to Stay Ahead of Variants

The UK has announced a further £29.3 million to stay on top of SARS-CoV-2 variants, the Guardian reports.

Push for Access

In a letter, researchers in India seek easier access to COVID-19 data, Science reports.

Not as Cold

Late-stage trial results are expected soon for an RNA-based vaccine that could help meet global demand as it does not require very cold storage, the New York Times writes.

Genome Research Papers on Microbes' Effects on Host Transfer RNA, Honeybee Evolution, Single-Cell Histones

In Genome Research this week: influence of microbes on transfer RNA patterns, evolutionary relationships of honeybees, and more.